Cardiometabolic Disorders News

Non-nutritive artificial sweeteners may alter the intestinal and oral microbiome as well as glycemic levels of healthy adults with no cardiometabolic complications, according to a study published in Cell.

Irregular and long menstrual cycles were associated with elevated risk for incident CVD events, primarily CHD, according to research published in JAMA Network Open.

BOSTON — New drugs and devices can reduce weight and weight-related comorbidities, and physicians should optimize therapy choices for patients with several common conditions to reduce their cardiometabolic risk, according to a speaker.

Adults with diabetes in Ontario, Canada, had a greater reduction in risk for cardiovascular events from 1994 to 2014 compared with adults with prior CV disease, according to a research letter published in JAMA.

Adults with type 2 diabetes and chronic kidney disease using the nonsteroidal mineralocorticoid receptor antagonist finerenone have lower risks for pneumonia and COVID-19, according to findings published in JAMA Network Open.

Research published in The Journal of Clinical Endocrinology & Metabolism highlighted the need for better evidence on long-term health consequences of gestational diabetes.

BOSTON — Optimizing HF therapy is the best way to reduce disease morbidity and mortality and clinicians should consider personalizing and titrating guideline-directed medical therapy based on patient comorbidities, according to a speaker.

BOSTON — The medical community is better equipped to combat residual CVD risk than previously, but prevention of residual risk should be tailored using a precision medicine approach, a speaker said at the Cardiometabolic Health Congress.

BOSTON — Finerenone reduces CV and renal events in patients with type 2 diabetes and chronic kidney disease, and albuminuria is a good screening tool to identify candidates, according to a speaker.

BOSTON — Reducing overall carbohydrate intake and eating more non-starchy vegetables and whole foods can help improve health outcomes for people with diabetes, according to a speaker at the Cardiometabolic Health Congress.